Inventor
LOW PHILIP STEWART
US48 patents
⚠️ This page may combine multiple inventors who share the name “LOW PHILIP STEWART”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PURDUE RESEARCH FOUNDATION
37 patentsUS9951324B2Apr 24, 2018
PSMA binding ligand-linker conjugates and methods for using
PURDUE RESEARCH FOUNDATION36 citations96
US5820847AOct 13, 1998
Method for targeting a diagnostic agent to cells
PURDUE RESEARCH FOUNDATION110 citations95
US5688488ANov 18, 1997
Composition and method for tumor imaging
PURDUE RESEARCH FOUNDATION213 citations95
US11717514B2Aug 8, 2023
PSMA binding ligand-linker conjugates and methods for using
PURDUE RESEARCH FOUNDATION7 citations94
US11369590B2Jun 28, 2022
PSMA binding ligand-linker conjugates and methods for using
PURDUE RESEARCH FOUNDATION10 citations94
US11318121B2May 3, 2022
PSMA binding ligand-linker conjugates and methods for using
PURDUE RESEARCH FOUNDATION9 citations94
US7033594B2Apr 25, 2006
Method of treatment using ligand-immunogen conjugates
PURDUE RESEARCH FOUNDATION116 citations94
US7977058B2Jul 12, 2011
Diagnostic method for atherosclerosis
PURDUE RESEARCH FOUNDATION15 citations92
US11872291B2Jan 16, 2024
Fibroblast activation protein (FAP)-targeted imaging and therapy
PURDUE RESEARCH FOUNDATION5 citations84
US10363250B2Jul 30, 2019
Folate receptor binding conjugates of antifolates
PURDUE RESEARCH FOUNDATION4 citations84
US9549992B2Jan 24, 2017
Folate receptor binding conjugates of antifolates
PURDUE RESEARCH FOUNDATION6 citations84
US11155800B2Oct 26, 2021
PSMA binding ligand-linker conjugates and methods for using
PURDUE RESEARCH FOUNDATION5 citations83
US10557128B2Feb 11, 2020
PSMA binding ligand-linker conjugates and methods for using
PURDUE RESEARCH FOUNDATION9 citations83
US9629918B2Apr 25, 2017
Folate receptor alpha binding ligands
PURDUE RESEARCH FOUNDATION7 citations78
US9279813B2Mar 8, 2016
Ex vivo flow cytometry method and device
PURDUE RESEARCH FOUNDATION5 citations73
US12269862B2Apr 8, 2025
Methods of use for CAR T cells
PURDUE RESEARCH FOUNDATION2 citations72
US12133900B2Nov 5, 2024
Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors
PURDUE RESEARCH FOUNDATION2 citations72
US12091693B2Sep 17, 2024
PSMA binding ligand-linker conjugates and methods for using
PURDUE RESEARCH FOUNDATION2 citations72
US11850262B2Dec 26, 2023
Compositions and methods for CAR T cell therapy
PURDUE RESEARCH FOUNDATION4 citations72
US11344623B2May 31, 2022
Cholecystokinin B receptor targeting for imaging and therapy
PURDUE RESEARCH FOUNDATION2 citations72
US10406238B2Sep 10, 2019
Ligand ionophore conjugates
PURDUE RESEARCH FOUNDATION4 citations72
US11883498B2Jan 30, 2024
Luteinizing hormone-releasing hormone receptor (LHRH-R) conjugates and uses thereof
PURDUE RESEARCH FOUNDATION1 citations71
US10821188B2Nov 3, 2020
Luteinizing hormone-releasing hormone receptor (LHRH-R) conjugates and uses thereof
PURDUE RESEARCH FOUNDATION4 citations71
US11890357B2Feb 6, 2024
Fibroblast activation protein (FAP) targeted imaging and therapy in fibrosis
PURDUE RESEARCH FOUNDATION2 citations68
US11426472B2Aug 30, 2022
Fibroblast activation protein (FAP) targeted imaging and therapy in fibrosis
PURDUE RESEARCH FOUNDATION2 citations68
US12397069B2Aug 26, 2025
Fibroblast activation protein (FAP)-targeted imaging and therapy
PURDUE RESEARCH FOUNDATION1 citations63
US12576165B2Mar 17, 2026
Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors
PURDUE RESEARCH FOUNDATION0 citations62
US11219622B2Jan 11, 2022
Folate receptor binding conjugates of antifolates
PURDUE RESEARCH FOUNDATION0 citations62
US12508319B2Dec 30, 2025
Luteinizing hormone-releasing hormone receptor (LHRH-R) conjugates and uses thereof
PURDUE RESEARCH FOUNDATION0 citations61
US12485179B2Dec 2, 2025
Cholecystokinin B receptor targeting for imaging and therapy
PURDUE RESEARCH FOUNDATION0 citations61
US12144850B2Nov 19, 2024
Methods and compositions for car T cell therapy
PURDUE RESEARCH FOUNDATION1 citations61
US12589155B2Mar 31, 2026
Efficient synthesis of lipid-fluorescein conjugates for CAR-T cell therapy
PURDUE RESEARCH FOUNDATION0 citations59
US12240870B2Mar 4, 2025
Sequencing method for CAR T cell therapy
PURDUE RESEARCH FOUNDATION1 citations56
US12397059B2Aug 26, 2025
Compounds and methods for the treatment and prevention of fibrotic disease states and cancer
PURDUE RESEARCH FOUNDATION0 citations54
US12319721B2Jun 3, 2025
Targeting anabolic drugs for accelerated fracture repair
PURDUE RESEARCH FOUNDATION0 citations53
US11185505B2Nov 30, 2021
Delivery of agents to inflamed tissues using folate-targeted liposomes
PURDUE RESEARCH FOUNDATION1 citations53
US12473264B2Nov 18, 2025
Inhibitors of erythrocyte band 3 tyrosine phosphorylation and uses thereof
PURDUE RESEARCH FOUNDATION0 citations50
LOW PHILIP STEWART
7 patentsUS9193763B2Nov 24, 2015
PSMA binding ligand-linker conjugates and methods for using
LOW PHILIP STEWART46 citations98
US8685752B2Apr 1, 2014
Ex vivo flow cytometry method and device
LOW PHILIP STEWART8 citations84
US8795633B2Aug 5, 2014
Multiphoton in vivo flow cytometry method and device
LOW PHILIP STEWART7 citations79
US8586595B2Nov 19, 2013
Positron emission tomography imaging method
LOW PHILIP STEWART9 citations76
US8105608B2Jan 31, 2012
Method of treatment using ligand-immunogen conjugates
LOW PHILIP STEWART2 citations58
US8961926B2Feb 24, 2015
Method of imaging localized infections
LOW PHILIP STEWART2 citations55
US8168164B2May 1, 2012
Targeted conjugates and radiation
LOW PHILIP STEWART2 citations53